Literature DB >> 30681401

High Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Isolated from Clinical Settings in Egypt: Recalling for Judicious Use of Conventional Antimicrobials in Developing Nations.

Hazim O Khalifa1,2, Ahmed M Soliman3,4, Ashraf M Ahmed5, Toshi Shimamoto3, Hirofumi Nariya3, Tetsuya Matsumoto1, Tadashi Shimamoto3.   

Abstract

This study was designed to investigate, at the molecular level, the antimicrobial resistance mechanisms of different antimicrobial resistance genes, including, extended-spectrum β-lactamases, AmpC β-lactamases, class 1 and 2 integrons, and plasmid-mediated quinolone resistance genes of Gram-negative bacteria isolated from clinical settings in Egypt. A total of 126 nonduplicate Gram-negative isolates were recovered from different clinical samples taken from hospitalized patients in Egypt in 2014. Antimicrobial susceptibility testing showed that, 93.6% (118/126) of the isolates had a multidrug-resistant phenotype. Interestingly, we reported a high level of antimicrobial resistance nearly for all tested antibiotics; to our knowledge, this is the first report from Egypt indicating very high level of antibiotic resistance in Egypt. Polymerase chain reaction screening and DNA sequencing revealed that, 75.4% (95/126) of the isolates harbored at least one extended-spectrum β-lactamase-encoding gene, with blaCTX-M being the most prevalent (65.9%), followed by blaSHV (46.8%). The AmpC β-lactamase, blaCMY, was detected in 7.1% (9/126) of bacterial isolates, with blaCMY-42 being the most prevalent. Class 1 integrons were detected in 50.8% (64/126) of the isolates, and class 2 integrons were detected in 2.4% (3/126) of the isolates. The plasmid-mediated quinolone resistance gene, qnr, was detected in 58.7% (74/126) of the tested isolates, with qnrS being the most prevalent. Several antimicrobial resistance determinants were identified in Egypt for the first time, such as SHV-27, SHV-28, SHV-33, SHV-63, SHV-71, SHV-82, SHV-142, CMY-42, CMY-6, and the new CMY-72 like. This study highlights the importance of the conscious use of conventional antimicrobials to overcome the multidrug resistance problem.

Entities:  

Keywords:  Egypt; antimicrobial resistance; extended-spectrum β-lactamases; multidrug-resistant bacteria

Mesh:

Substances:

Year:  2019        PMID: 30681401     DOI: 10.1089/mdr.2018.0380

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  10 in total

1.  Emergence of Salmonella Genomic Island 1 Variant SGI1-C in a Multidrug-Resistant Clinical Isolate of Klebsiella pneumoniae ST485 from Egypt.

Authors:  Ahmed M Soliman; Hazem Ramadan; Eslam Ghazy; Liansheng Yu; Junzo Hisatsune; Shizuo Kayama; Motoyuki Sugai; Hirofumi Nariya; Toshi Shimamoto; Charlene R Jackson; Tadashi Shimamoto
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

2.  First Report of Multidrug-Resistant Carbapenemase-Producing Bacteria Coharboring mcr-9 Associated with Respiratory Disease Complex in Pets: Potential of Animal-Human Transmission.

Authors:  Hazim O Khalifa; Atef F Oreiby; Amer Ali Abd El-Hafeez; Takashi Okanda; Anwaral Haque; Kazi S Anwar; Masaki Tanaka; Keisuke Miyako; Shoji Tsuji; Yasuyuki Kato; Tetsuya Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

3.  Determination of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolated from horses with respiratory manifestation.

Authors:  Amany A Arafa; Riham H Hedia; Sohad M Dorgham; Eman S Ibrahim; Magdy A Bakry; Abeer M Abdalhamed; Azza S M Abuelnaga
Journal:  Vet World       Date:  2022-04-06

4.  High β-lactam resistance in Gram-negative bacteria associated with kennel cough and cat flu in Egypt.

Authors:  Hazim O Khalifa; Atef F Oreiby; Takashi Okanda; Yasuyuki Kato; Tetsuya Matsumoto
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.996

5.  Prevalence and antimicrobial susceptibility profile of multidrug-resistant bacteria among intensive care units patients at Ain Shams University Hospitals in Egypt-a retrospective study.

Authors:  Noha Alaa Eldin Fahim
Journal:  J Egypt Public Health Assoc       Date:  2021-03-29

6.  High Rates of Aminoglycoside Methyltransferases Associated with Metallo-Beta-Lactamases in Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Clinical Isolates from a Tertiary Care Hospital in Egypt.

Authors:  Amira El-Far; Safia Samir; Eman El-Gebaly; Maysa Omar; Heba Dahroug; Ahmed El-Shenawy; Noha Salah Soliman; Doaa Gamal
Journal:  Infect Drug Resist       Date:  2021-11-19       Impact factor: 4.003

7.  Synergistic Antibacterial Potential of 6-Pentyl-α-pyrone Lactone and Zinc Oxide Nanoparticles against Multidrug-Resistant Enterobacterales Isolated from Urinary Tract Infections in Humans.

Authors:  Ahmed M E Kotb; Norhan K Abd El-Aziz; Eman Y T Elariny; Reham Yahya; Dalal Hussien M Alkhalifah; Rania M Ahmed
Journal:  Antibiotics (Basel)       Date:  2022-03-24

8.  Prevalence and Molecular Characterization of Extended-Spectrum β-Lactamases and AmpC β-lactamase-Producing Enterobacteriaceae among Human, Cattle, and Poultry.

Authors:  Mohamed A Nossair; Fatma A Abd El Baqy; Mohammad S Y Rizk; Haitham Elaadli; Alaa M Mansour; Ayman H Abd El-Aziz; Adil Alkhedaide; Mohamed Mohamed Soliman; Hazem Ramadan; Mustafa Shukry; Sabah I Shaaban
Journal:  Pathogens       Date:  2022-07-28

9.  Distribution of Extended-Spectrum β-Lactamase (ESBL)-Encoding Genes among Multidrug-Resistant Gram-Negative Pathogens Collected from Three Different Countries.

Authors:  Khaled S M Azab; Mohamed Ali Abdel-Rahman; Hussien H El-Sheikh; Ehab Azab; Adil A Gobouri; Mohamed M S Farag
Journal:  Antibiotics (Basel)       Date:  2021-03-02

10.  Emergence of Multidrug-Resistant Escherichia coli Producing CTX-M, MCR-1, and FosA in Retail Food From Egypt.

Authors:  Hazem Ramadan; Ahmed M Soliman; Lari M Hiott; Mohammed Elbediwi; Tiffanie A Woodley; Marie A Chattaway; Claire Jenkins; Jonathan G Frye; Charlene R Jackson
Journal:  Front Cell Infect Microbiol       Date:  2021-07-13       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.